Page last updated: 2024-10-30

leflunomide and Alopecia Cicatrisata

leflunomide has been researched along with Alopecia Cicatrisata in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"Alopecia areata is the third most common cause of dermatology consultations in children but the treatment of paediatric alopecia areata remains challenging."2.72Therapeutic management in paediatric alopecia areata: A systematic review. ( Kołodziejak, M; Olszewska, M; Rakowska, A; Rudnicka, L; Sikora, M; Stochmal, A; Waśkiel-Burnat, A, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Waśkiel-Burnat, A1
Kołodziejak, M1
Sikora, M1
Stochmal, A1
Rakowska, A1
Olszewska, M1
Rudnicka, L1

Reviews

1 review available for leflunomide and Alopecia Cicatrisata

ArticleYear
Therapeutic management in paediatric alopecia areata: A systematic review.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:6

    Topics: Adolescent; Alopecia; Alopecia Areata; Child; Humans; Janus Kinase Inhibitors; Leflunomide; Minoxidi

2021